Lexology May 23, 2024
A recently announced settlement with online alcohol addiction treatment service Monument Inc. demonstrates the Federal Trade Commission’s (FTC) continued focus on the use and disclosure of health data. The proposed settlement follows a string of FTC enforcement actions in this space, including those involving health companies GoodRx and BetterHelp. If approved, the stipulated order would prohibit Monument from disclosing users’ health information for many advertising purposes.
The complaint alleges violations of the FTC Act and the Opioid Addiction Recovery Fraud Prevention Act of 2018 (OARFPA), which permits the FTC to seek civil penalties for unfair or deceptive acts or practices with respect to any substance use disorder treatment service or substance use disorder treatment product.
While many of the remedies...